Buscar
01/03/2026
Gleason pattern 4 and active surveillance in patients with grade group 2 prostate cancer
Uleri, A, Baboudjian, M, Leni, R, Oderda, M, Peyrottes, A, Kesch, C, Al-Nader, M, Dariane, C, Baud, H, Olivier, J, Rios, AR, Sanguedolce, F, Benard, V, Windisch, O, Valerio, M, Gandaglia, G, Ploussard, G. Gleason pattern 4 and active surveillance in patients with grade group 2 prostate cancer. PROSTATE CANCER AND PROSTATIC DISEASES. 2026; 29(1)DOI:10.1038/s41391-025-00977-6. PMID:40301553. IF:5.800(Q1/1D).
01/03/2026
International Delphi consensus on UTUC management: The IMPACT UTUC project
Pandolfo, SD, Contieri, R, Catto, J, Briganti, A, Roupret, M, Pradere, B, Porpiglia, F, Amparore, D, Minervini, A, Bertolo, R, Moschini, M, Mertens, L, Rhijn, BWGV, Gallioli, A, Formisano, L, Imbimbo, C, Lucarelli, G, Ferro, M, Gupta, S, Mir, MC, Derweesh,, Djaladat, H, Bukavina, L, Autorino, R. International Delphi consensus on UTUC management: The IMPACT UTUC project. EUROPEAN UROLOGY. 2026; 89DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2026
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders
Bolsewig, K, Bellomo, G, Hok-A-Hin, YS, Al Idrissi, I, Vermunt, L, Lleó, A, Alcolea, D, Sieben, A, Engelborghs, S, Simonsen, AH, Hasselbalch, SG, Bech, S, Morrema, THJ, Hoozemans, JJM, Bol, JGJM, Van Alphen, J, Gaetani, L, Chiasserini, D, Paoletti, FP, Parnetti, L, Kang, SW, Lee, YG, Jeon, S, Lee, AH, Jeon, S, Ye, BS, Milán, MD, Van Der Flier, WM, Van De Berg, WDJ, Lemstra, AW, Willemse, EAJ, Teunissen, CE. A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders. NATURE MEDICINE. 2026; 32(3)DOI:10.1038/s41591-026-04212-0. PMID:41699128. IF:50.000(Q1/1D).
01/03/2026
Neoadjuvant radiotherapy for primary retroperitoneal well-differentiated liposarcoma: a Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) propensity score matched analysis
Fairweather, M, Sulciner, M, Jolissaint, JS, Fiore, M, Ortega, DYG, Iwata, S, Ford, SJ, Swallow, C, Nizri, E, Quagliuolo, V, Nessim, C, Adamkova, D, Rutkowski, P, Cardona, K, Kim, E, Porpiglia, AS, Johnston, FM, Gyorki, DE, Vincenzi, B, Corina, KF, Kramer, S, Blazer, D, Tseng, WW, Albertsmeier, M, González, JA, Hompes, D, Baldini, EH, Gronchi, A, Rauta, CP. Neoadjuvant radiotherapy for primary retroperitoneal well-differentiated liposarcoma: a Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) propensity score matched analysis. Eclinicalmedicine. 2026; 93DOI:10.1016/j.eclinm.2026.103805. PMID:41783086. IF:10.000(Q1/1D).